These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Erratum: Publisher Correction to BioMed Central EJNMMI Radiopharm Chem; 2018 Dec; 3():13. PubMed ID: 31329807 [TBL] [Abstract][Full Text] [Related]
9. Erratum: Publisher Correction to: Multiple articles in Food Science and Biotechnology. Publisher Food Sci Biotechnol; 2018 Aug; 27(4):1245. PubMed ID: 30265261 [TBL] [Abstract][Full Text] [Related]
10. Correction to: Volume 2 Issue 1 of PNAS Nexus; 2023 Jan; 2(1):pgad016. PubMed ID: 36744020 [TBL] [Abstract][Full Text] [Related]
11. Erratum: Publisher Correction: articles initially published in wrong volume. Cell Death Discov; 2019; 5():116. PubMed ID: 31312525 [TBL] [Abstract][Full Text] [Related]
12. Corrigendum to Davies SJ, Zhao J, Morgenstern H, et al. Low Serum Potassium Levels and Clinical Outcomes in Peritoneal Dialysis-International Results from PDOPPS. Kidney Int Rep; 2021 May; 6(5):1485. PubMed ID: 34013134 [TBL] [Abstract][Full Text] [Related]
13. Corrigendum to Shi M, Yu S, Ouyang Y, et al. Increased lifetime risk of ESRD in familial IgA nephropathy. Kidney Int Rep; 2021 May; 6(5):1484. PubMed ID: 34013133 [TBL] [Abstract][Full Text] [Related]
14. Erratum: Ismail H, Abdul Manaf MR, Abdul Gafor AH, et al. Economic burden of ESRD to the Malaysian health care system. Kidney Int Rep; 2019 Dec; 4(12):1770. PubMed ID: 31844816 [TBL] [Abstract][Full Text] [Related]
15. Correction. Int J Dev Disabil; 2021; 67(6):458-459. PubMed ID: 35111303 [TBL] [Abstract][Full Text] [Related]
16. Erratum: Evans M, Grams ME, Sang Y, et al., for the Chronic Kidney Disease Prognosis Consortium. Risk factors for prognosis in patients with severely decreased GFR. Chronic Kidney Disease Prognosis Consortium Kidney Int Rep; 2018 Nov; 3(6):1506. PubMed ID: 30450480 [TBL] [Abstract][Full Text] [Related]
17. Corrigendum to "Zand L, Canetta P, Lafayette R, et al. An open-label pilot study of adrenocorticotrophic hormone in the treatment of IgA nephropathy at high risk of progression." Kidney Int Rep; 2020 Mar; 5(3):382. PubMed ID: 32154464 [TBL] [Abstract][Full Text] [Related]
18. Erratum to "Perrone RD, Chapman AB, Oberdhan D, et al. The NOCTURNE Randomized Trial Comparing 2 Tolvaptan Formulations." Kidney Int Rep; 2020 Dec; 5(12):2407-2408. PubMed ID: 33305145 [TBL] [Abstract][Full Text] [Related]
19. Erratum: Ganesh K, Nair RR, Kurian G, et al. Posterior reversible encephalopathy syndrome in kidney disease. Kidney Int Rep; 2018 May; 3(3):765. PubMed ID: 29855628 [TBL] [Abstract][Full Text] [Related]
20. Corrigendum to "Cataldo E, Cinquantini F, Priola AM, et al. Spontaneous renal artery dissection in Ehler-Danlos syndrome." Kidney Int Rep; 2020 Mar; 5(3):382. PubMed ID: 32154462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]